These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9568232)

  • 61. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
    Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
    Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
    MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
    [No Abstract]   [Full Text] [Related]  

  • 63. Role of leukotrienes and leukotriene receptor antagonists in asthma.
    Jones TR; Rodger IW
    Pulm Pharmacol Ther; 1999; 12(2):107-10. PubMed ID: 10373391
    [No Abstract]   [Full Text] [Related]  

  • 64. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
    J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New treatments for asthma: the role of leukotriene modifier agents.
    Valacer DJ
    J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
    Szefler SJ; Carlsson LG; Uryniak T; Baker JW
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Taking a look at new advances in asthma therapy.
    Anderson P
    Community Nurse; 1999 Jun; 5(5):19-20. PubMed ID: 10513546
    [No Abstract]   [Full Text] [Related]  

  • 68. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
    Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
    Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment.
    Hung CH; Jong YJ; Hua YM; Li CY; Lai YS; Yang KD; Chang HC
    Pulm Pharmacol Ther; 2007; 20(3):233-9. PubMed ID: 17276712
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing risk: Data from montelukast clinical trials.
    Kelsay K
    J Allergy Clin Immunol; 2009 Oct; 124(4):697-8. PubMed ID: 19815115
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
    Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
    Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Montelukast protects against bradykinin-induced bronchospasm.
    Crimi N; Mastruzzo C; Pagano C; Lisitano N; Palermo F; Vancheri C
    J Allergy Clin Immunol; 2005 Apr; 115(4):870-2. PubMed ID: 15806012
    [No Abstract]   [Full Text] [Related]  

  • 73. [Leukotriene antagonism. Inhibiting inflammation plus bronchodilatation].
    MMW Fortschr Med; 2000 Nov; 142(46):62-3. PubMed ID: 11138591
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical evidence with montelukast in the management of chronic childhood asthma.
    Becker A
    Drugs; 2000; 59 Suppl 1():29-34; discussion 43-5. PubMed ID: 10741880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Montelukast: UK regulator says asthma drug needs clearer warnings of side effects.
    Iacobucci G
    BMJ; 2024 May; 385():q1048. PubMed ID: 38719533
    [No Abstract]   [Full Text] [Related]  

  • 76. Wheezing in young children: WAITing for pharmacogenomics?
    Becker AB; Paré PD
    Lancet Respir Med; 2014 Oct; 2(10):776-7. PubMed ID: 25239795
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of montelukast on markers of airway remodeling in children with asthma.
    Tenero L; Piazza M; Sandri M; Azzali A; Chinellato I; Peroni D; Boner A; Piacentini G
    Allergy Asthma Proc; 2016 Sep; 37(5):77-83. PubMed ID: 27657514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of exercise training and montelukast in children with mild asthma.
    Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
    Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.